GLAXOSMITHKLINE PHARMACEUTICALS
|
The Current P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 11.61.
| Share Price | ₹2,605.8 | Feb 17,2026 |
| Market Cap | ₹44,141.4 Cr | |
| Sales-TTM | ₹3,800.7 Cr | TTM-Consolidated Results |
| Price/Sales | 11.61x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of GLAXOSMITHKLINE PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹44,141.4 Cr] as on Feb 17,2026
(/) Sales [ ₹3,800.7 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 11.61x ]
Thus, for GLAXOSMITHKLINE PHARMACEUTICALS , the investors are currently willing to pay '11.61 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLAXOSMITHKLINE PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLAXOSMITHKLINE PHARMACEUTICALS
PS Ratio Performance Analysis for GLAXOSMITHKLINE PHARMACEUTICALS
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 9.27x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's operated at median p/e ratio of 8.59x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 13x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 6.9x.
How does GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| GLAXOSMITHKLINE PHARMACEUTICALS | 3,800.7 | 11.61 | 44,141.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.25 | 412,062.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.92 | 164,192.0 |
| CIPLA LTD | 28,351.1 | 3.83 | 108,513.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.31 | 144,129.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.09 | 107,250.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.12 | 85,198.8 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.50 | 91,240.3 |
| LUPIN LTD | 26,150.5 | 3.93 | 102,734.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.07 | 68,804.7 |
| ABBOTT INDIA LTD | 6,824.1 | 8.25 | 56,313.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.07x |
| Max industry PS | 15.92x |
| Median industry PS | 6.12x |
| Average industry PS | 6.99x |
You may also like the below Video Courses